RTI Surgical Inc (RTIX) reported quarterly earnings results on Thursday, Apr-28-2016. The company reported $0.03 EPS for the quarter. Analysts had a consensus estimate of $0.03. The company posted revenue of $67.40 million in the period, compared to analysts expectations of $65.49 million. The company’s revenue was down -.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.05 EPS.
RTI Surgical Inc opened for trading at $4.18 and hit $4.49 on the upside on Wednesday, eventually ending the session at $4.33, with a gain of 2.85% or 0.12 points. The heightened volatility saw the trading volume jump to 3,01,746 shares. Company has a market cap of $250 M.
RTI Surgical Inc. produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. The Company uses natural tissues metals and synthetics process to produce its products. The Company processes donated human musculoskeletal and other tissue including bone cartilage tendon ligament fascia lata pericardium sclera and dermal tissue and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE TUTOPLAST and CANCELLE SP sterilization processes and manufacture metal and synthetic implants for distribution to hospitals and surgeons. The Company’s business has six categories: spine sports medicine ortho fixation bone graft substitutes and general orthopedic (BGS and general orthopedic) surgical specialties and dental. The Company distributes its implants and services in all 50 states and in over 45 countries worldwide.